{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:16:00Z","timestamp":1790972160878,"version":"4.1.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/nrrheum.2017.56","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:31:24Z","timestamp":1493253084000},"page":"359-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":286,"title":["Pathogenesis of ankylosing spondylitis \u2014 recent advances and future directions"],"prefix":"10.1038","volume":"13","author":[{"given":"Vidya","family":"Ranganathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigil","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"key":"BFnrrheum201756_CR1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrrheum.2012.42","volume":"8","author":"L Van Praet","year":"2012","unstructured":"Van Praet, L., Jacques, P., Van Den Bosch, F., & Elewaut, D. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat. Rev. Rheumatol. 8, 288\u2013295 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum201756_CR2","doi-asserted-by":"crossref","first-page":"e0130811","DOI":"10.1371\/journal.pone.0130811","volume":"10","author":"O Marroquin Belaunzaran","year":"2015","unstructured":"Marroquin Belaunzaran, O. et al. HLA-B27-homodimer-specific antibody modulates the expansion of pro-inflammatory T-cells in HLA-B27 transgenic rats. PLoS ONE 10, e0130811 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201756_CR3","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten, D. et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382, 1705\u20131713 (2013).","journal-title":"Lancet"},{"key":"BFnrrheum201756_CR4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton, D. A. et al. Ankylosing spondylitis and HL-A 27. Lancet 1, 904\u2013907 (1973).","journal-title":"Lancet"},{"key":"BFnrrheum201756_CR5","doi-asserted-by":"crossref","unstructured":"The Australo-Anglo-American Spondyloarthritis Consortium et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761\u2013767 (2011).","DOI":"10.1038\/ng0911-919a"},{"key":"BFnrrheum201756_CR6","doi-asserted-by":"crossref","unstructured":"Wellcome Trust Case Control Consortium et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329\u20131337 (2007).","DOI":"10.1038\/ng.2007.17"},{"key":"BFnrrheum201756_CR7","doi-asserted-by":"crossref","unstructured":"International Genetics of Ankylosing Spondylitis Consortium et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 45, 730\u2013738 (2013).","DOI":"10.1038\/ng.2667"},{"key":"BFnrrheum201756_CR8","doi-asserted-by":"crossref","unstructured":"Australo-Anglo-American Spondyloarthritis Consortium et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet. 42, 123\u2013127 (2010).","DOI":"10.1038\/ng.513"},{"key":"BFnrrheum201756_CR9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","volume":"48","author":"D Ellinghaus","year":"2016","unstructured":"Ellinghaus, D. et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48, 510\u2013518 (2016).","journal-title":"Nat. Genet."},{"key":"BFnrrheum201756_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrrheum.2015.133","volume":"12","author":"MA Brown","year":"2016","unstructured":"Brown, M. A., Kenna, T. & Wordsworth, B. P. Genetics of ankylosing spondylitis \u2014 insights into pathogenesis. Nat. Rev. Rheumatol. 12, 81\u201391 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum201756_CR11","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1038\/ncomms8146","volume":"6","author":"A Cortes","year":"2015","unstructured":"Cortes, A. et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat. Commun. 6, 7146 (2015).","journal-title":"Nat. Commun."},{"key":"BFnrrheum201756_CR12","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/anr.1780320912","volume":"32","author":"WP Robinson","year":"1989","unstructured":"Robinson, W. P. et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum. 32, 1135\u20131141 (1989).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201756_CR13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.55.4.268","volume":"55","author":"MA Brown","year":"1996","unstructured":"Brown, M. A. et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann. Rheum. Dis. 55, 268\u2013270 (1996).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s13075-015-0855-3","volume":"17","author":"K Kim","year":"2015","unstructured":"Kim, K. et al. An HLA-C amino-acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population. Arthritis Res. Ther. 17, 342 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201756_CR15","doi-asserted-by":"crossref","unstructured":"Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2 et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42, 985\u2013990 (2010).","DOI":"10.1038\/ng.694"},{"key":"BFnrrheum201756_CR16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Y Kirino","year":"2013","unstructured":"Kirino, Y. et al. Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1. Nat. Genet. 45, 202\u2013207 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrrheum201756_CR17","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1093\/hmg\/ddu307","volume":"23","author":"JJ Kuiper","year":"2014","unstructured":"Kuiper, J. J. et al. A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy. Hum. Mol. Genet. 23, 6081\u20136087 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrrheum201756_CR18","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1074\/mcp.M115.048959","volume":"14","author":"C Alvarez-Navarro","year":"2015","unstructured":"Alvarez-Navarro, C., Martin-Esteban, A., Barnea, E., Admon, A. & Lopez de Castro, J. A. Endoplasmic reticulum aminopeptidase 1 (ERAP1) polymorphism relevant to inflammatory disease shapes the peptidome of the birdshot chorioretinopathy-associated HLA-A*29:02 antigen. Mol. Cell. Proteomics 14, 1770\u20131780 (2015).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFnrrheum201756_CR19","doi-asserted-by":"crossref","first-page":"19030","DOI":"10.1073\/pnas.1106408108","volume":"108","author":"P Rausch","year":"2011","unstructured":"Rausch, P. et al. Colonic mucosa-associated microbiota is influenced by an interaction of crohn disease and FUT2 (Secretor) genotype. Proc. Natl Acad. Sci. USA 108, 19030\u201319035 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201756_CR20","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.38967","volume":"67","author":"ME Costello","year":"2014","unstructured":"Costello, M. E. et al. Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol. 67, 686\u2013691 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/annrheumdis-2014-206484","volume":"75","author":"DD O'Rielly","year":"2015","unstructured":"O'Rielly, D. D. et al. Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritis. Ann. Rheum. Dis. 75, 772\u2013779 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","volume":"33","author":"P Bowness","year":"2015","unstructured":"Bowness, P. Hla-B27. Annu. Rev. Immunol. 33, 29\u201348 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum201756_CR23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11926-013-0362-y","volume":"15","author":"MA Khan","year":"2013","unstructured":"Khan, M. A. Polymorphism of HLA-B27: 105 subtypes currently known. Curr. Rheumatol. Rep. 15, 362 (2013).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum201756_CR24","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1074\/mcp.M114.039214","volume":"13","author":"N Garcia-Medel","year":"2014","unstructured":"Garcia-Medel, N. et al. Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1). Mol. Cell. Proteomics 13, 3367\u20133380 (2014).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFnrrheum201756_CR25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.38963","volume":"67","author":"RB Schittenhelm","year":"2015","unstructured":"Schittenhelm, R. B., Sian, T. C., Wilmann, P. G., Dudek, N. L. & Purcell, A. W. Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes. Arthritis Rheumatol. 67, 702\u2013713 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR26","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1074\/mcp.M115.056358","volume":"15","author":"RB Schittenhelm","year":"2016","unstructured":"Schittenhelm, R. B., Sivaneswaran, S., Lim Kam Sian, T. C., Croft, N. P. & Purcell, A. W. Human leukocyte antigen (HLA) B27 allotype-specific binding and candidate arthritogenic peptides revealed through heuristic clustering of data-independent acquisition mass spectrometry (DIA-MS) data. Mol. Cell. Proteomics 15, 1867\u20131876 (2016).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFnrrheum201756_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20031690","volume":"199","author":"M Hulsmeyer","year":"2004","unstructured":"Hulsmeyer, M. et al. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J. Exp. Med. 199, 271\u2013281 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum201756_CR28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2016.03.009","volume":"70","author":"O Rysnik","year":"2016","unstructured":"Rysnik, O. et al. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. J. Autoimmun. 70, 12\u201321 (2016).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum201756_CR29","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/rheumatology\/kev218","volume":"54","author":"TJ Kenna","year":"2015","unstructured":"Kenna, T. J., Robinson, P. C. & Haroon, N. Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitis. Rheumatology (Oxford) 54, 1549\u20131556 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201756_CR30","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.4049\/jimmunol.162.9.5045","volume":"162","author":"RL Allen","year":"1999","unstructured":"Allen, R. L., O'Callaghan, C. A., McMichael, A. J. & Bowness, P. Cutting edge: HLA-B27 can form a novel \u03b22-microglobulin-free heavy chain homodimer structure. J. Immunol. 162, 5045\u20135048 (1999).","journal-title":"J. Immunol."},{"key":"BFnrrheum201756_CR31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.0105-2896.2009.00865.x","volume":"233","author":"RA Colbert","year":"2010","unstructured":"Colbert, R. A., DeLay, M. L., Klenk, E. I. & Layh-Schmitt, G. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol. Rev. 233, 181\u2013202 (2010).","journal-title":"Immunol. Rev."},{"key":"BFnrrheum201756_CR32","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","volume":"73","author":"F Ciccia","year":"2013","unstructured":"Ciccia, F. et al. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann. Rheum. Dis. 73, 1566\u20131574 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/annrheumdis-2013-204170","volume":"73","author":"B Neerinckx","year":"2014","unstructured":"Neerinckx, B., Carter, S. & Lories, R. J. No evidence for a critical role of the unfolded protein response in synovium and blood of patients with ankylosing spondylitis. Ann. Rheum. Dis. 73, 629\u2013630 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR34","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s10067-016-3262-5","volume":"35","author":"F Ciccia","year":"2016","unstructured":"Ciccia, F. & Haroon, N. Autophagy in the pathogenesis of ankylosing spondylitis. Clin. Rheumatol. 35, 1433\u20131436 (2016).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum201756_CR35","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1136\/annrheumdis-2014-206277","volume":"73","author":"B Neerinckx","year":"2014","unstructured":"Neerinckx, B., Carter, S. & Lories, R. IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis. Response to: 'Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation' by Ciccia et al. Ann. Rheum. Dis. 73, e68 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR36","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/art.38809","volume":"66","author":"DB Guiliano","year":"2014","unstructured":"Guiliano, D. B. et al. Endoplasmic reticulum degradation-enhancing \u03b1-mannosidase-like protein 1 targets misfolded HLA-B27 dimers for endoplasmic reticulum-associated degradation. Arthritis Rheumatol. 66, 2976\u20132988 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR37","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","volume":"186","author":"P Bowness","year":"2011","unstructured":"Bowness, P. et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J. Immunol. 186, 2672\u20132680 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum201756_CR38","first-page":"79","volume":"20","author":"H Abdullah","year":"2015","unstructured":"Abdullah, H., Zhang, Z., Yee, K. & Haroon, N. KIR3DL1 interaction with HLA-B27 is altered by ankylosing spondylitis associated ERAP1 and enhanced by MHC class I cross-linking. Discov. Med. 20, 79\u201389 (2015).","journal-title":"Discov. Med."},{"key":"BFnrrheum201756_CR39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/art.39515","volume":"68","author":"A Ridley","year":"2016","unstructured":"Ridley, A. et al. Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis. Arthritis Rheumatol. 68, 901\u2013914 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni1208","volume":"6","author":"L Saveanu","year":"2005","unstructured":"Saveanu, L. et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6, 689\u2013697 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum201756_CR41","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1073\/pnas.0500721102","volume":"102","author":"SC Chang","year":"2005","unstructured":"Chang, S. C., Momburg, F., Bhutani, N. & Goldberg, A. L. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a \u201cmolecular ruler\u201d mechanism. Proc. Natl Acad. Sci. USA 102, 17107\u201317112 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201756_CR42","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ni859","volume":"3","author":"T Saric","year":"2002","unstructured":"Saric, T. et al. An IFN-\u03b3-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3, 1169\u20131176 (2002).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum201756_CR43","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1073\/pnas.1101262108","volume":"108","author":"G Kochan","year":"2011","unstructured":"Kochan, G. et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc. Natl Acad. Sci. USA 108, 7745\u20137750 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201756_CR44","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/annrheumdis-2014-206996","volume":"75","author":"L Chen","year":"2016","unstructured":"Chen, L. et al. Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis. Ann. Rheum. Dis. 75, 916\u2013923 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR45","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.1003337","volume":"186","author":"I Evnouchidou","year":"2011","unstructured":"Evnouchidou, I. et al. Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J. Immunol. 186, 1909\u20131913 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum201756_CR46","doi-asserted-by":"crossref","first-page":"17594","DOI":"10.1073\/pnas.1408882111","volume":"111","author":"E Reeves","year":"2014","unstructured":"Reeves, E., Colebatch-Bourn, A., Elliott, T., Edwards, C. J. & James, E. Functionally distinct ERAP1 allotype combinations distinguish individuals with ankylosing spondylitis. Proc. Natl Acad. Sci. USA 111, 17594\u201317599 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201756_CR47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/annrheumdis-2011-200347","volume":"71","author":"N Haroon","year":"2012","unstructured":"Haroon, N., Tsui, F. W., Uchanska-Ziegler, B., Ziegler, A. & Inman, R. D. Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Ann. Rheum. Dis. 71, 589\u2013595 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR48","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1074\/mcp.M112.019588","volume":"11","author":"N Garcia-Medel","year":"2012","unstructured":"Garcia-Medel, N. et al. Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol. Cell. Proteomics 11, 1416\u20131429 (2012).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFnrrheum201756_CR49","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.4049\/jimmunol.1400343","volume":"192","author":"A Akram","year":"2014","unstructured":"Akram, A., Lin, A., Gracey, E., Streutker, C. J. & Inman, R. D. HLA-B27, but not HLA-B7, immunodominance to influenza is ERAP dependent. J. Immunol. 192, 5520\u20135528 (2014).","journal-title":"J. Immunol."},{"key":"BFnrrheum201756_CR50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2016.04.002","volume":"74","author":"TM Tran","year":"2016","unstructured":"Tran, T. M., Hong, S., Edwan, J. H. & Colbert, R. A. ERAP1 reduces accumulation of aberrant and disulfide-linked forms of HLA-B27 on the cell surface. Mol. Immunol. 74, 10\u201317 (2016).","journal-title":"Mol. Immunol."},{"key":"BFnrrheum201756_CR51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/gene.2014.62","volume":"16","author":"TJ Kenna","year":"2014","unstructured":"Kenna, T. J. et al. Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis. Genes Immun. 16, 35\u201342 (2014).","journal-title":"Genes Immun."},{"key":"BFnrrheum201756_CR52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.2008.103804","volume":"69","author":"FW Tsui","year":"2010","unstructured":"Tsui, F. W. et al. Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann. Rheum. Dis. 69, 733\u2013736 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR53","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4049\/jimmunol.1302855","volume":"193","author":"I Evnouchidou","year":"2014","unstructured":"Evnouchidou, I., Weimershaus, M., Saveanu, L. & van Endert, P. ERAP1\u2013ERAP2 dimerization increases peptide-trimming efficiency. J. Immunol. 193, 901\u2013908 (2014).","journal-title":"J. Immunol."},{"key":"BFnrrheum201756_CR54","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1136\/annrheumdis-2015-207467","volume":"74","author":"PC Robinson","year":"2015","unstructured":"Robinson, P. C. et al. ERAP2 functional knockout in humans does not alter surface heavy chains or HLA-B27, inflammatory cytokines or endoplasmic reticulum stress markers. Ann. Rheum. Dis. 74, 2092\u20132095 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR55","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39734","volume":"68","author":"A Martin-Esteban","year":"2016","unstructured":"Martin-Esteban, A., Guasp, P., Barnea, E., Admon, A. & Lopez de Castro, J. A. Functional interaction of the ankylosing spondylitis associated endoplasmic reticulum aminopeptidase 2 with the HLA-B*27 peptidome in human cells. Arthritis Rheumatol. 68, 2466\u20132475 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR56","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2006.11.005","volume":"74","author":"D Wendling","year":"2007","unstructured":"Wendling, D., Cedoz, J. P., Racadot, E. & Dumoulin, G. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 74, 304\u2013305 (2007).","journal-title":"Joint Bone Spine"},{"key":"BFnrrheum201756_CR57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","volume":"30","author":"Y Mei","year":"2011","unstructured":"Mei, Y. et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin. Rheumatol. 30, 269\u2013273 (2011).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum201756_CR58","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.24568","volume":"60","author":"H Shen","year":"2009","unstructured":"Shen, H., Goodall, J. C. & Hill Gaston, J. S. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 60, 1647\u20131656 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201756_CR59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/art.33321","volume":"64","author":"S Glatigny","year":"2012","unstructured":"Glatigny, S. et al. Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis Rheum. 64, 110\u2013120 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201756_CR60","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.38638","volume":"66","author":"H Benham","year":"2014","unstructured":"Benham, H. et al. Interleukin-23 mediates the intestinal response to microbial \u03b2-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol. 66, 1755\u20131767 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR61","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/art.39464","volume":"68","author":"E Gracey","year":"2016","unstructured":"Gracey, E. et al. Sexual dimorphism in the Th17 signature of ankylosing spondylitis. Arthritis Rheumatol. 68, 679\u2013689 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.38291","volume":"66","author":"JA Smith","year":"2014","unstructured":"Smith, J. A. & Colbert, R. A. Review: the interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond. Arthritis Rheumatol. 66, 231\u2013241 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR63","first-page":"261","volume":"76","author":"MC Lau","year":"2016","unstructured":"Lau, M. C. et al. Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis. Ann. Rheum. Dis. 76, 261\u2013269 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR64","doi-asserted-by":"crossref","first-page":"11627","DOI":"10.1038\/ncomms11627","volume":"7","author":"T Krausgruber","year":"2016","unstructured":"Krausgruber, T. et al. T-bet is a key modulator of IL-23-driven pathogenic CD4+ T cell responses in the intestine. Nat. Commun. 7, 11627 (2016).","journal-title":"Nat. Commun."},{"key":"BFnrrheum201756_CR65","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1126\/science.aaf3892","volume":"352","author":"T Sujino","year":"2016","unstructured":"Sujino, T. et al. Tissue adaptation of regulatory and intraepithelial CD4+ T cells controls gut inflammation. Science 352, 1581\u20131586 (2016).","journal-title":"Science"},{"key":"BFnrrheum201756_CR66","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","volume":"75","author":"E Gracey","year":"2016","unstructured":"Gracey, E. et al. IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis. Ann. Rheum. Dis. 75, 2124\u20132132 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR67","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3899\/jrheum.151133","volume":"43","author":"E Hayashi","year":"2016","unstructured":"Hayashi, E. et al. Involvement of mucosal-associated invariant T cells in ankylosing spondylitis. J. Rheumatol. 43, 1695\u20131703 (2016).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201756_CR68","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","volume":"74","author":"F Ciccia","year":"2015","unstructured":"Ciccia, F. et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann. Rheum. Dis. 74, 1739\u20131747 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR69","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/art.23998","volume":"58","author":"M Rihl","year":"2008","unstructured":"Rihl, M. et al. Identification of interleukin-7 as a candidate disease mediator in spondylarthritis. Arthritis Rheum. 58, 3430\u20133435 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201756_CR70","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","volume":"64","author":"TJ Kenna","year":"2012","unstructured":"Kenna, T. J. et al. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive \u03b3\/\u03b4 T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 64, 1420\u20131429 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201756_CR71","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock, J. P. et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4\u2212CD8\u2212 entheseal resident T cells. Nat. Med. 18, 1069\u20131076 (2012).","journal-title":"Nat. Med."},{"key":"BFnrrheum201756_CR72","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39732","volume":"68","author":"A Reinhardt","year":"2016","unstructured":"Reinhardt, A. et al. IL-23-dependent \u03b3\/\u03b4 T cells produce IL-17 and accumulate in enthesis, aortic valve, and ciliary body. Arthritis Rheumatol. 68, 2476\u20132486 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR73","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1038\/ncomms10928","volume":"7","author":"T Ono","year":"2016","unstructured":"Ono, T. et al. IL-17-producing \u03b3\u03b4 T cells enhance bone regeneration. Nat. Commun. 7, 10928 (2016).","journal-title":"Nat. Commun."},{"key":"BFnrrheum201756_CR74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4419-0298-6_4","volume":"649","author":"M Benjamin","year":"2009","unstructured":"Benjamin, M. & McGonagle, D. The enthesis organ concept and its relevance to the spondyloarthropathies. Adv. Exp. Med. Biol. 649, 57\u201370 (2009).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrrheum201756_CR75","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/art.22758","volume":"56","author":"D McGonagle","year":"2007","unstructured":"McGonagle, D., Lories, R. J., Tan, A. L. & Benjamin, M. The concept of a \u201csynovio\u2013entheseal complex\u201d and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum. 56, 2482\u20132491 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201756_CR76","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","volume":"73","author":"P Jacques","year":"2014","unstructured":"Jacques, P. et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann. Rheum. Dis. 73, 437\u2013445 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR77","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.34355","volume":"64","author":"F Ciccia","year":"2012","unstructured":"Ciccia, F. et al. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis Rheum. 64, 1869\u20131878 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201756_CR78","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.aaa4812","volume":"348","author":"MR Hepworth","year":"2015","unstructured":"Hepworth, M. R. et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells. Science 348, 1031\u20131035 (2015).","journal-title":"Science"},{"key":"BFnrrheum201756_CR79","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","volume":"43","author":"JS Lee","year":"2015","unstructured":"Lee, J. S. et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43, 727\u2013738 (2015).","journal-title":"Immunity"},{"key":"BFnrrheum201756_CR80","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991\u2013999 (2012).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum201756_CR81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12036","volume":"252","author":"LA Zuniga","year":"2013","unstructured":"Zuniga, L. A., Jain, R., Haines, C. & Cua, D. J. Th17 cell development: from the cradle to the grave. Immunol. Rev. 252, 78\u201388 (2013).","journal-title":"Immunol. Rev."},{"key":"BFnrrheum201756_CR82","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235\u2013238 (2006).","journal-title":"Nature"},{"key":"BFnrrheum201756_CR83","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan, P. R. et al. Transforming growth factor-\u03b2 induces development of the TH17 lineage. Nature 441, 231\u2013234 (2006).","journal-title":"Nature"},{"key":"BFnrrheum201756_CR84","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi, K. et al. Generation of pathogenic TH17 cells in the absence of TGF-\u03b2 signalling. Nature 467, 967\u2013971 (2010).","journal-title":"Nature"},{"key":"BFnrrheum201756_CR85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature14452","volume":"523","author":"N Gagliani","year":"2015","unstructured":"Gagliani, N. et al. TH17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221\u2013225 (2015).","journal-title":"Nature"},{"key":"BFnrrheum201756_CR86","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aaa9420","volume":"349","author":"E Sefik","year":"2015","unstructured":"Sefik, E. et al. Mucosal immunology. Individual intestinal symbionts induce a distinct population of ROR\u03b3+ regulatory T cells. Science 349, 993\u2013997 (2015).","journal-title":"Science"},{"key":"BFnrrheum201756_CR87","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.aac4263","volume":"349","author":"C Ohnmacht","year":"2015","unstructured":"Ohnmacht, C. et al. Mucosal immunology. The microbiota regulates type 2 immunity through ROR\u03b3+ T cells. Science 349, 989\u2013993 (2015).","journal-title":"Science"},{"key":"BFnrrheum201756_CR88","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.immuni.2015.08.019","volume":"43","author":"JR Maxwell","year":"2015","unstructured":"Maxwell, J. R. et al. Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation. Immunity 43, 739\u2013750 (2015).","journal-title":"Immunity"},{"key":"BFnrrheum201756_CR89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.immuni.2015.11.009","volume":"44","author":"R Jain","year":"2016","unstructured":"Jain, R. et al. Interleukin-23-induced transcription factor Blimp-1 promotes pathogenicity of T helper 17 cells. Immunity 44, 131\u2013142 (2016).","journal-title":"Immunity"},{"key":"BFnrrheum201756_CR90","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.gastro.2013.04.040","volume":"145","author":"D Ellinghaus","year":"2013","unstructured":"Ellinghaus, D. et al. Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology 145, 339\u2013347 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrrheum201756_CR91","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B","volume":"44","author":"D Baeten","year":"2001","unstructured":"Baeten, D. et al. Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum. 44, 186\u2013195 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201756_CR92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2008.102277","volume":"69","author":"N Haroon","year":"2008","unstructured":"Haroon, N. et al. From gene expression to serum proteins: biomarker discovery in ankylosing spondylitis. Ann. Rheum. Dis. 69, 297\u2013300 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR93","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13075-016-0949-6","volume":"18","author":"FM Milanez","year":"2016","unstructured":"Milanez, F. M. et al. IL-23\/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients. Arthritis Res. Ther. 18, 52 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201756_CR94","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1038\/ncomms4199","volume":"5","author":"HG Evans","year":"2014","unstructured":"Evans, H. G. et al. TNF-alpha blockade induces IL-10 expression in human CD4+ T cells. Nat. Commun. 5, 3199 (2014).","journal-title":"Nat. Commun."},{"key":"BFnrrheum201756_CR95","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/annrheumdis-2013-203559","volume":"73","author":"J Sieper","year":"2014","unstructured":"Sieper, J., Porter-Brown, B., Thompson, L., Harari, O. & Dougados, M. Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials. Ann. Rheum. Dis. 73, 95\u2013100 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR96","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/annrheumdis-2013-204963","volume":"74","author":"J Sieper","year":"2015","unstructured":"Sieper, J. et al. Sarilumab for the treatment of ankylosing spondylitis: results of a phase II, randomized, double-blind, placebo-controlled, international study (ALIGN). Ann. Rheum. Dis. 74, 1051\u20131057 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR97","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"NJ Wilson","year":"2007","unstructured":"Wilson, N. J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950\u2013957 (2007).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum201756_CR98","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","volume":"73","author":"D Poddubnyy","year":"2014","unstructured":"Poddubnyy, D., Hermann, K. G., Callhoff, J., Listing, J. & Sieper, J. Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS). Ann. Rheum. Dis. 73, 817\u2013823 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR99","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.1968","volume":"15","author":"C Yao","year":"2009","unstructured":"Yao, C. et al. Prostaglandin E2\u2013EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion. Nat. Med. 15, 633\u2013640 (2009).","journal-title":"Nat. Med."},{"key":"BFnrrheum201756_CR100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.4046","volume":"22","author":"DR Withers","year":"2016","unstructured":"Withers, D. R. et al. Transient inhibition of ROR-\u03b3t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells. Nat. Med. 22, 319\u2013323 (2016).","journal-title":"Nat. Med."},{"key":"BFnrrheum201756_CR101","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jaci.2015.09.048","volume":"137","author":"J de Wit","year":"2016","unstructured":"de Wit, J. et al. ROR\u03b3t inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease. J. Allergy Clin. Immunol. 137, 960\u2013963 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrrheum201756_CR102","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber, W. et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61, 1693\u20131700 (2012).","journal-title":"Gut"},{"issue":"Suppl.","key":"BFnrrheum201756_CR103","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/annrheumdis-2016-eular.3684","volume":"75","author":"S Schreiber","year":"2016","unstructured":"Schreiber, S. et al. OP0113 No increased incidence of inflammatory bowel disease among secukinumab-treated patients with moderate to severe psoriasis, psoriatic arthritis, or ankylosing spondylitis: data from 14 phase 2 and phase 3 clinical studies [abstract]. Ann. Rheum. Dis. 75 (Suppl.), 97\u201398 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201756_CR104","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/BOR.0000000000000299","volume":"28","author":"M Asquith","year":"2016","unstructured":"Asquith, M. & Rosenbaum, J. T. The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathies. Curr. Opin. Rheumatol. 28, 405\u2013412 (2016).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201756_CR105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrrheum.2016.85","volume":"12","author":"T Van de Wiele","year":"2016","unstructured":"Van de Wiele, T., Van Praet, J. T., Marzorati, M., Drennan, M. B. & Elewaut, D. How the microbiota shapes rheumatic diseases. Nat. Rev. Rheumatol. 12, 398\u2013411 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum201756_CR106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/art.39802","volume":"69","author":"RY Tito","year":"2016","unstructured":"Tito, R. Y. et al. Dialister as microbial marker of disease activity in spondyloarthritis. Arthritis Rheumatol. 69, 114\u2013121 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR107","doi-asserted-by":"crossref","first-page":"e105684","DOI":"10.1371\/journal.pone.0105684","volume":"9","author":"P Lin","year":"2014","unstructured":"Lin, P. et al. HLA-B27 and human \u03b22-microglobulin affect the gut microbiota of transgenic rats. PLoS ONE 9, e105684 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201756_CR108","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/art.38773","volume":"66","author":"LM Rehaume","year":"2014","unstructured":"Rehaume, L. M. et al. ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice. Arthritis Rheumatol. 66, 2780\u20132792 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR109","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","volume":"180","author":"JD Taurog","year":"1994","unstructured":"Taurog, J. D. et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180, 2359\u20132364 (1994).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum201756_CR110","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.39041","volume":"67","author":"AC Baillet","year":"2015","unstructured":"Baillet, A. C. et al. High chlamydia burden promotes tumor necrosis factor-dependent reactive arthritis in SKG mice. Arthritis Rheumatol. 67, 1535\u20131547 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201756_CR111","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.34423","volume":"64","author":"M Ruutu","year":"2012","unstructured":"Ruutu, M. et al. \u03b2-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. Arthritis Rheum. 64, 2211\u20132222 (2012).","journal-title":"Arthritis Rheum."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.56","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrrheum.2017.56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T20:43:10Z","timestamp":1750192990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2017.56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFnrrheum201756"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2017.56","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]},"assertion":[{"value":"27 April 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}